July 6, 2008 "the introduction of the two-ticket system will have an impact on the pharmaceutical production enterprises, pharmaceutical circulation enterprises and other subjects." A pharmaceutical listed company previously told the securities daily newspaper. With this policy change, pharmaceutical circulation enterprises will face integration and future pharmaceutical production enterprises will also face marketing and promotion changes.
The two-ticket system speeded up
It is understood that the drug from the manufacturer to the patient has to go through layers of price, which leads to the price of some drugs. To counter the problems existing in the medicine circulation field, since last year, state regulators take more means of implementing two votes (production enterprise to open an invoice of enterprises and circulation enterprises to open an invoice) of medical institutions, in order to reduce the cost of medicine circulation.
To this end, the general office of the state council issued a number of opinions on further reform and improvement of the policy on the use of drug production and circulation (hereinafter referred to as the opinion). "Opinion" resolving the outstanding issues in medical industry, from the drugs production, circulation, use the whole chain, the whole process, the system reform measures are put forward, clearly put forward to in 2018 opened the drug procurement "two votes" across the country.
According to the securities daily, there have been a two-ticket implementation scheme (trial) in 25 places and a timetable has been made. According to understand, more to the implementation of two votes set up not long transition period at the same time, some parts 5 months, 3 months, some area allows the pharmaceutical production, circulation enterprises and public medical institution during the transition period of time to digest inventory, adjust and reconstruct pharmaceutical supply chain system.
For the two-ticket system, different regions have given different regulations, and the main body recognition and implementation procedures of the production enterprises which have been closely watched by the market have their own characteristics.
The cognizance of the production enterprises, for example, recently released "on drugs issued by the Shanghai public medical institutions procurement projects (trial)" two votes "notice, according to Shanghai for two votes of is: pharmaceutical production enterprise to open an invoice of enterprises and circulation enterprises to open an invoice of medical institutions. Among them, the pharmaceutical production enterprise of the integration of trade and industry or group of enterprises to establish sales only wholly owned or holding of this enterprise (group) pharmaceutical commercial company (national only 1 business companies), foreign drug domestic general agent (the only one domestic general agent) can be regarded as production enterprise.
And the guangxi zhuang autonomous region public medical institutions and drug procurement "two votes" implementation plan (try out) "enterprise standards for production to" relax ", namely the drug marketing authorisation holder compliance entrust responsible for drug production enterprise or business (only 1 companies across the country), can be regarded as production enterprise.
There are also different steps in some areas to implement a two-ticket system. For example, the public medical institutions in the province have formally implemented the "two-ticket system". In some areas, local characteristics have been developed gradually.
The pharmaceutical industry is fully reshuffled
The "two-ticket" rollout first had an impact on pharmaceutical companies. Analysts believe that the "two votes" the compressed pharmaceutical circulation, medicine circulation industry will further integrate, most small and medium-sized uncompetitive commercial enterprises will gradually disappear, strong comprehensive competitiveness of large pharmaceutical circulation enterprises have obvious benefit.
In the personage inside course of study, however, in the field of pharmaceutical commercial enterprises there are many callings, a ticket, falsely making out invoice is qualitative as violation of historical existence, thus leading to integration of business enterprise may carry on the tax risk, the current business enterprise integration than expected.
Moreover, the impact of this policy on pharmaceutical companies cannot be ignored. Earlier, shi lichen, founder of the third party medical services platform, maxwell house, told reporters that there are currently thousands of pharmaceutical companies in China, but there are not many pharmaceutical companies with proprietary teams. Most enterprises still focus on agency mode. With policies such as the two-ticket system pushed aside, the marketing of pharmaceutical companies without a self-supporting team will be unsustainable.
This has increased the cost of running a company to a certain extent, a person from a listed company in the pharmaceutical industry told reporters.
|
